Since miR-221 and miR-222 are known to target ETS2 and ETS1, respectively, in matured blood vessel endothelial cells [31], we tested whether ETS1 and ETS2 levels in late EPCs from CAD patients. Here, ETS1 is linked to coronary artery disorder.